Home

ProQuest Associates IV LLC

CIK 1431819 · last filed 2017-04-03

ProQuest Associates IV LLC is a corporate insider who has filed 14 SEC Form 4 insider transactions across 1 company since 2014. The most recent filing shows the insider sold $37.9M of EGRX on Apr 3, 2017. Across all open-market trades the lifetime net is −$252.4M, making them a net seller over the disclosed history. The firm reports its address in Naples, FL. 45 SEC filings were submitted jointly with ProQuest Investments IV, L.P.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$0

Companies

1

Total Filings

14

Lifetime Open-Market Net

-$252.45M

Filer Profile

Reported Address
2430 VANDERBILT BEACH ROAD
#108 - 190
NAPLES, FL 34109
Phone
(609) 919-3567
State of Incorporation
DE
Related Filers
ProQuest Investments IV, L.P. — 45 joint filings, latest 2017-11-29
Jay Moorin — 43 joint filings, latest 2017-11-29
ALAIN SCHREIBER — 43 joint filings, latest 2017-11-29
ProQuest Financial LLC — 17 joint filings, latest 2017-05-15
ProQuest Management LLC — 6 joint filings, latest 2016-05-24
ProQuest Associates III LLC — 4 joint filings, latest 2016-01-29
ProQuest Investments III, L.P. — 4 joint filings, latest 2016-01-29
Profile details as reported on the filer's SEC submissions — for individual insiders the address is often in care of the issuer. Related filers are identified from jointly filed SEC submissions and shared reported addresses. View filings on SEC EDGAR.

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
EAGLE PHARMACEUTICALS, INC. (EGRX) Delisted 10%+ Owner 6,777 $2.14 $14.5K -$252.45M 9 2017-04-03

Recent Filings

14 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2017-04-03 EAGLE PHARMACEUTICALS, INC. (EGRX) Delisted Sell (S) −456,660 -$37.95M EDGAR
2017-03-23 EAGLE PHARMACEUTICALS, INC. (EGRX) Delisted Sell (S) −6,000 -$498.3K EDGAR
2017-03-20 EAGLE PHARMACEUTICALS, INC. (EGRX) Delisted Sell (S) −500,000 -$41.03M EDGAR
2016-11-09 EAGLE PHARMACEUTICALS, INC. (EGRX) Delisted Sell (S) −769,150 -$60.99M EDGAR
2016-11-04 EAGLE PHARMACEUTICALS, INC. (EGRX) Delisted Sell (S) −1,228,850 -$87.28M EDGAR
2016-08-25 EAGLE PHARMACEUTICALS, INC. (EGRX) Delisted Sell (S) −144,350 -$9.09M EDGAR
2016-08-17 EAGLE PHARMACEUTICALS, INC. (EGRX) Delisted Sell (S) −498,975 -$30.62M EDGAR
2015-05-13 — Sell (S) −710,428 -$15.34M
2015-05-07 EAGLE PHARMACEUTICALS, INC. (EGRX) Delisted Other (J) −49,515 $0 EDGAR
2015-04-21 — Sell (S) −183,280 -$4.86M
Showing 1–10 of 14
Page 1 of 2
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.